{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T22:02:51Z","timestamp":1764540171447,"version":"3.46.0"},"reference-count":39,"publisher":"Practical Medicine Publishing House","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Background &amp; Aims.\u00a0New schemes of the antitumor therapy of CLL resulted in improvement of survival of relatively young patients. However, the therapy outcomes of elderly patients are still unsatisfactory. Erroneous overestimation of expected toxicity of standard therapeutic regimens in some elderly patients may play a certain role, thus leading to prescription of less effective regimens. Therefore, the urgent problem is to find objective criteria for risk stratification in CLL. The aim of the study is to evaluate the prognostic significance of patient\u2019s age and the CIRS-G index in elderly patients treated with fludarabine-containing regimens in first line treatment outside clinical trials.\r\nMethods.\u00a0A retrospective analysis of 90 elderly CLL patients, treated with standard FC and FCR regimens in the clinic of internal medicine of the First St. Petersburg State Medical University from 2001 till 2011. The age median was 59 years (range from 43 to 78 years). The comorbidity index was determined for each patient using the CIRS-G score.\r\nResults.\u00a0The overall response rate did not significantly differ between FC and FCR groups and was equal to 81.6\u00a0% and 93.4\u00a0%, respectively (p\u00a0=\u00a00.109). Complete remissions were achieved in 72.3\u00a0% of FCR group patients and only in 46.5\u00a0% of FC group patients (p\u00a0=\u00a00.018). The retrospective analysis of treatment tolerability in primary elderly patients with different CIRS-G scores in the routine clinical practice demonstrated that the index has no independent prognostic significance. Among all CIRS-G components (14 organs and systems), only renal and hepatic diseases demonstrated significant correlation with the overall survival rate (p\u00a0&lt;\u00a00.001 and\u00a0p\u00a0=\u00a00.028, respectively).\r\nConclusion.\u00a0The creatinine clearance value in the beginning of treatment is the most important predictor of FC and FCR regimen efficacy in elderly patients. The use of the comorbidity index with a 6-score threshold as a contraindication for fludarabine-containing regimens proved to be unjustified.<\/jats:p>","DOI":"10.21320\/2500-2139-2016-9-2-162-175","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T18:18:02Z","timestamp":1467224282000},"page":"162-175","source":"Crossref","is-referenced-by-count":3,"title":["Role of Patient\u2019s Age and Comorbidities in Therapy of Chronic Lymphocytic Leukemia","\u0417\u043d\u0430\u0447\u0435\u043d\u0438\u0435 \u0432\u043e\u0437\u0440\u0430\u0441\u0442\u0430 \u0438 \u0441\u043e\u043f\u0443\u0442\u0441\u0442\u0432\u0443\u044e\u0449\u0438\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439 \u0432 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u043b\u0438\u043c\u0444\u043e\u043b\u0435\u0439\u043a\u043e\u0437\u0430"],"prefix":"10.21320","volume":"9","author":[{"given":"Vladimir Vladimirovich","family":"Strugov","sequence":"first","affiliation":[{"name":"V.A. Almazov Federal North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0421\u0435\u0432\u0435\u0440\u043e-\u0417\u0430\u043f\u0430\u0434\u043d\u044b\u0439 \u0444\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u0412.\u0410. \u0410\u043b\u043c\u0430\u0437\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u0410\u043a\u043a\u0443\u0440\u0430\u0442\u043e\u0432\u0430, \u0434. 2, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 197341"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Stadnik","sequence":"additional","affiliation":[{"name":"V.A. Almazov Federal North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341; Academician I.P. Pavlov First St. Petersburg State Medical University, 6\/8 L\u2019va Tolstogo str., Saint Petersburg, Russian Federation, 197022"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0421\u0435\u0432\u0435\u0440\u043e-\u0417\u0430\u043f\u0430\u0434\u043d\u044b\u0439 \u0444\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u0412.\u0410. \u0410\u043b\u043c\u0430\u0437\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u0410\u043a\u043a\u0443\u0440\u0430\u0442\u043e\u0432\u0430, \u0434. 2, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 197341; \u0413\u0411\u041e\u0423 \u0412\u041f\u041e \u00ab\u041f\u0435\u0440\u0432\u044b\u0439 \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433\u0441\u043a\u0438\u0439 \u0433\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442 \u0438\u043c. \u0430\u043a\u0430\u0434. \u0418.\u041f. \u041f\u0430\u0432\u043b\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u041b\u044c\u0432\u0430 \u0422\u043e\u043b\u0441\u0442\u043e\u0433\u043e, \u0434. 6\/8, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 197022"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu. V.","family":"Virts","sequence":"additional","affiliation":[{"name":"V.A. Almazov Federal North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0421\u0435\u0432\u0435\u0440\u043e-\u0417\u0430\u043f\u0430\u0434\u043d\u044b\u0439 \u0444\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u0412.\u0410. \u0410\u043b\u043c\u0430\u0437\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u0410\u043a\u043a\u0443\u0440\u0430\u0442\u043e\u0432\u0430, \u0434. 2, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 197341"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. O.","family":"Silina","sequence":"additional","affiliation":[{"name":"V.A. Almazov Federal North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0421\u0435\u0432\u0435\u0440\u043e-\u0417\u0430\u043f\u0430\u0434\u043d\u044b\u0439 \u0444\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u0412.\u0410. \u0410\u043b\u043c\u0430\u0437\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u0410\u043a\u043a\u0443\u0440\u0430\u0442\u043e\u0432\u0430, \u0434. 2, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 197341"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Yu.","family":"Zaritskii","sequence":"additional","affiliation":[{"name":"V.A. Almazov Federal North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341; Academician I.P. Pavlov First St. Petersburg State Medical University, 6\/8 L\u2019va Tolstogo str., Saint Petersburg, Russian Federation, 197022"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0421\u0435\u0432\u0435\u0440\u043e-\u0417\u0430\u043f\u0430\u0434\u043d\u044b\u0439 \u0444\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u0412.\u0410. \u0410\u043b\u043c\u0430\u0437\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u0410\u043a\u043a\u0443\u0440\u0430\u0442\u043e\u0432\u0430, \u0434. 2, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 197341; \u0413\u0411\u041e\u0423 \u0412\u041f\u041e \u00ab\u041f\u0435\u0440\u0432\u044b\u0439 \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433\u0441\u043a\u0438\u0439 \u0433\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442 \u0438\u043c. \u0430\u043a\u0430\u0434. \u0418.\u041f. \u041f\u0430\u0432\u043b\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u041b\u044c\u0432\u0430 \u0422\u043e\u043b\u0441\u0442\u043e\u0433\u043e, \u0434. 6\/8, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 197022"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"17014","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.606386"},{"key":"17015","doi-asserted-by":"publisher","DOI":"10.1586\/era.10.127"},{"key":"17016","unstructured":"\u041e\u0436\u0438\u0434\u0430\u0435\u043c\u0430\u044f \u043f\u0440\u043e\u0434\u043e\u043b\u0436\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u044c \u043f\u0440\u0435\u0434\u0441\u0442\u043e\u044f\u0449\u0435\u0439 \u0436\u0438\u0437\u043d\u0438 \u043f\u043e \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u0438 [\u044d\u043b\u0435\u043a\u0442\u0440\u043e\u043d\u043d\u044b\u0439 \u0434\u043e\u043a\u0443\u043c\u0435\u043d\u0442]. \u0414\u043e\u0441\u0442\u0443\u043f\u043d\u043e \u043f\u043e: http:\/\/www.gks.ru\/free_doc\/new_site\/population\/generation\/dem2.xlsx. \u0421\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 15.08.2015."},{"key":"17017","unstructured":"[Ozhidaemaya prodolzhitel\u2019nost\u2019 predstoyashchei zhizni po Rossiiskoi Federatsii. (Life expectancy in the Russian Federation.) [Internet] Available from: http:\/\/www.gks.ru\/free_doc\/new_site\/population\/generation\/dem2.xlsx. (accessed 15.08.2015) (In Russ)]"},{"key":"17018","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-140582"},{"key":"17019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61381-5"},{"key":"17020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-214346"},{"key":"17021","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-015-0454-0"},{"key":"17022","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"17023","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4"},{"key":"17024","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701724785"},{"key":"17025","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2013.814845"},{"key":"17026","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.096792"},{"key":"17027","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802688517"},{"key":"17028","unstructured":"Miller M, Towers A. A manual of guidelines for scoring the cumulative illness rating scale for geriatrics (CIRS-G). May 1991. [Internet] Available from: http:\/\/www.anq.ch\/fileadmin\/redaktion\/deutsch\/20121211_CIRSG_Manual_E.pdf. (accessed 12.04.2016)."},{"key":"17029","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.4156.4156"},{"key":"17030","doi-asserted-by":"crossref","unstructured":"\u041d\u0438\u043a\u0438\u0442\u0438\u043d \u0415.\u0410., \u0425\u0430\u043b\u043b\u0435\u043a \u041c., \u0411\u0430\u0439\u043a\u043e\u0432 \u0412.\u0412. \u0438 \u0434\u0440. \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0435 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 \u043f\u043e \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0435 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u044e \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u043b\u0438\u043c\u0444\u043e\u043b\u0435\u0439\u043a\u043e\u0437\u0430 (\u0432\u0435\u0440\u0441\u0438\u044f 2012 \u0433.). \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043e\u043d\u043a\u043e\u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f. 2013;6(1):99\u2013109.","DOI":"10.21320\/2500-2139-2013-6-1-99-109"},{"key":"17031","unstructured":"[Nikitin EA, Khallek M, Baykov VV, et al. Russian clinical guidelines for diagnosis and treatment of chronic lymphocytic leukemia (version 2012). Klinicheskaya onkogematologiya. 2013;6(1):99\u2013109. (In Russ)]"},{"key":"17032","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.2.494"},{"key":"17033","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2015.03.003"},{"key":"17034","unstructured":"\u0421\u0442\u0440\u0443\u0433\u043e\u0432 \u0412.\u0412., \u0421\u0442\u0430\u0434\u043d\u0438\u043a \u0415.\u0410., \u0412\u0438\u0440\u0446 \u042e.\u0412., \u0417\u0430\u0440\u0438\u0446\u043a\u0438\u0439 \u0410.\u042e. \u0420\u0435\u0442\u0440\u043e\u0441\u043f\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u043e\u0432 \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044f \u0440\u0435\u0436\u0438\u043c\u043e\u0432 FC\/FCR \u0432 \u043f\u0435\u0440\u0432\u043e\u0439 \u043b\u0438\u043d\u0438\u0438 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u043b\u0438\u043c\u0444\u043e\u043b\u0435\u0439\u043a\u043e\u0437\u0430. \u0422\u0440\u0430\u043d\u0441\u043b\u044f\u0446\u0438\u043e\u043d\u043d\u0430\u044f \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0430. 2012;6(17):104\u201315."},{"key":"17035","unstructured":"[Strugov VV, Stadnik EA, Virts YuV, Zaritskii AYu. Retrospective studies of outcomes of FC\/FCR regimens in first-line therapy if chronic lymphocytic leukemia. Translyatsionnaya meditsina. 2012;6(17):104\u201315. (In Russ)]"},{"key":"17036","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.01935.x"},{"key":"17037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.3745"},{"key":"17038","unstructured":"\u0421\u0442\u0430\u0434\u043d\u0438\u043a \u0415.\u0410., \u041d\u0438\u043a\u0438\u0442\u0438\u043d \u0415.\u0410., \u0411\u0438\u0434\u0435\u0440\u043c\u0430\u043d \u0411.\u0412. \u0438 \u0434\u0440. \u0420\u0435\u0442\u0440\u043e\u0441\u043f\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0435 \u0441\u0440\u0430\u0432\u043d\u0435\u043d\u0438\u0435 \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u0438 \u0438 \u0442\u043e\u043a\u0441\u0438\u0447\u043d\u043e\u0441\u0442\u0438 \u0440\u0435\u0436\u0438\u043c\u043e\u0432 \u043b\u0435\u0447\u0435\u043d\u0438\u044f FC \u0438 FCR \u0443 \u043f\u0435\u0440\u0432\u0438\u0447\u043d\u044b\u0445 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0412-\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u044b\u043c \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u043c \u043b\u0438\u043c\u0444\u043e\u043b\u0435\u0439\u043a\u043e\u0437\u043e\u043c. \u041e\u043d\u043a\u043e\u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f. 2008;1\u20132:39\u201346."},{"key":"17039","unstructured":"[Stadnik EA, Nikitin EA, Biderman BV, et al. Comparison of efficacy and toxicity of FC and FCR regimens in the treatment of primary B-cell chronic lymphocytic leukemia: a retrospective study. Onkogematologiya. 2008;1\u20132:39\u201346. (In Russ)]"},{"key":"17040","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-051458"},{"key":"17041","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-556399"},{"key":"17042","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.107326"},{"key":"17043","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50007"},{"key":"17044","unstructured":"\u041f\u0438\u0433\u0430\u0440\u0435\u0432\u0430 \u042e.\u0410., \u0410\u0432\u0434\u043e\u0448\u0438\u043d\u0430 \u0421.\u0412., \u0414\u043c\u0438\u0442\u0440\u043e\u0432\u0430 \u0422.\u0411. \u0438 \u0434\u0440. \u0420\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u0438 \u043f\u043e\u0447\u0435\u043a \u0441\u0440\u0435\u0434\u0438 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0442\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0441\u0442\u0430\u0446\u0438\u043e\u043d\u0430\u0440\u0430. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043d\u0435\u0444\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2012;3:4\u20139."},{"key":"17045","unstructured":"[Pigareva YuA, Avdoshina SV, Dmitrova TB, et al. Prevalence of chronic kidney disease in patients of clinic of internal diseases. Klinicheskaya nefrologiya. 2012;3:4\u20139. (In Russ)]"},{"key":"17046","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-002-0443-5"},{"key":"17047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2013.01.002"},{"key":"17048","doi-asserted-by":"publisher","DOI":"10.1177\/2040620713478629"},{"key":"17049","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.19.19"},{"key":"17050","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313984"},{"key":"17051","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70513-8"},{"key":"17052","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0045"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/482\/446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/482\/446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:26:52Z","timestamp":1764502012000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2016-9-2-162-175","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"type":"electronic","value":"2500-2139"},{"type":"print","value":"1997-6933"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}